{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:10Z","timestamp":1790484130437,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.amjms.2021.07.009","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T01:04:31Z","timestamp":1629335071000},"page":"562-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recent Trends in Infective Endocarditis Among Patients with and Without Injection Drug Use: An Eight-Year Single Center Study"],"prefix":"10.1016","volume":"362","author":[{"given":"Javier","family":"Balda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Alpizar-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Elarabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand L.","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.amjms.2021.07.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.4150","article-title":"Trends and patterns of geographic variation in cardiovascular mortality among US counties, 1980-2014","volume":"317","author":"Roth","year":"2017","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.amjms.2021.07.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/heart.88.1.53","article-title":"Mortality from infective endocarditis: Clinical predictors of outcome","volume":"88","author":"Wallace","year":"2002","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.amjms.2021.07.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5220","article-title":"Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs","volume":"1","author":"Rodger","year":"2018","journal-title":"JAMA Netw open"},{"issue":"15","key":"10.1016\/j.amjms.2021.07.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1995.00430150125013","article-title":"Clinical Features, Site of Involvement, Bacteriologic Findings, and Outcome of Infective Endocarditis in Intravenous Drug Users","volume":"155","author":"Mathew","year":"1995","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.amjms.2021.07.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.amjms.2021.07.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1080\/21548331.2018.1435128","article-title":"Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding","volume":"46","author":"Ortwine","year":"2018","journal-title":"Hosp Pract (1995)"},{"issue":"3","key":"10.1016\/j.amjms.2021.07.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00112-12","article-title":"Comparative genomics of vancomycin-resistant staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant s. aureus hospital-acquired infection in the United States","volume":"3","author":"Kos","year":"2012","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.amjms.2021.07.009_bib0008","article-title":"Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.amjms.2021.07.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjms.2021.07.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: A prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.amjms.2021.07.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.amjms.2021.07.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.amjms.2021.07.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2003.029850","article-title":"Diagnostic criteria and problems in infective endocarditis","volume":"90","author":"Prendergast","year":"2004","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.amjms.2021.07.009_bib0014","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical Outcomes of Infective Endocarditis in Injection Drug Users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjms.2021.07.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2021.07.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80869-y","article-title":"Comparing right- and left sided injection-drug related infective endocarditis","volume":"11","author":"Clarelin","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.amjms.2021.07.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century The international collaboration on Endocarditis-prospective cohort study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.amjms.2021.07.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.168.19.2095","article-title":"Current features of infective endocarditis in elderly patients: Results of the international collaboration on endocarditis prospective cohort study","volume":"168","author":"Durante-Mangoni","year":"2008","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.amjms.2021.07.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082665","article-title":"Infective endocarditis epidemiology over five decades: A systematic review","volume":"8","author":"Slipczuk","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.amjms.2021.07.009_bib0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/dar.12228","article-title":"Evolving epidemiology of injecting drug use-associated infective endocarditis: A regional centre experience","volume":"34","author":"Tung","year":"2015","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.amjms.2021.07.009_bib0021","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0891-5520(02)00019-3","article-title":"Infective endocarditis in the injection drug user","volume":"16","author":"Brown","year":"2002","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.amjms.2021.07.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2011.08.016","article-title":"Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users","volume":"93","author":"Rabkin","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.amjms.2021.07.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003016","article-title":"Validated risk score for predicting 6-month mortality in infective endocarditis","volume":"5","author":"Park","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjms.2021.07.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2016.02.072","article-title":"Surgical outcomes of infective endocarditis among intravenous drug users","volume":"152","author":"Kim","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.amjms.2021.07.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.07.007","article-title":"Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN","volume":"170","author":"Desimone","year":"2015","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2021.07.009_bib0026","article-title":"Epidemiological trends of infective endocarditis: A population-based study in Olmsted County, Minnesota","volume":"85","author":"Correa De Sa","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"10.1016\/j.amjms.2021.07.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1995.00430150125013","article-title":"Clinical Features, Site of Involvement, Bacteriologic Findings, and Outcome of Infective Endocarditis in Intravenous Drug Users","volume":"155","author":"Mathew","year":"1995","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.amjms.2021.07.009_bib0028","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs \u2014 Six Sites, 2005\u20132016","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjms.2021.07.009_bib0029","doi-asserted-by":"crossref","unstructured":"CDC. Prevent Bacterial & Fungal Infections In Patients Who Inject Drugs. doi:10.15585\/mmwr.mm6722a2","DOI":"10.15585\/mmwr.mm6722a2"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:39:51Z","timestamp":1757702391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0002962921002792"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.07.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Trends in Infective Endocarditis Among Patients with and Without Injection Drug Use: An Eight-Year Single Center Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}